Year ender 2025: From Ozempic to Yeztugo; key new drug approvals in 2025 and why they matter

This year has been one for the books in medicine. From Ozempic’s expanded role in protecting failing kidneys to long‑acting ...
Oneindia

Drug Approvals in 2025 Signal Major Shifts in Chronic Care and Infection Control

In 2025, drug approvals widen treatment options for chronic diseases, infections and pain, including Ozempic kidney ...
Pharmabiz

Kymera Therapeutics receives US FDA Fast Track Designation for KT-621, an oral STAT6 degrader to treat atopic dermatitis

Kymera Therapeutics receives US FDA Fast Track Designation for KT-621, an oral STAT6 degrader to treat atopic dermatitis: Watertown, Massachusetts Saturday, December 13, 2025, 18: ...

Sanofi (SAN:CA) Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments Transcript

Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...
Le Lézard

PADCEVtm Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive topline results from an interim analysis of the Phase 3 EV-304 clinical trial ...
Health.com

5 Ways To Treat Your Ear Infection at Home

Arno Kroner, DAOM, LAc, operates a private practice in Santa Monica where he specializes in acupuncture, herbal medicine, and integrative medicine. OTC pain relievers like Tylenol and ibuprofen can ...